皮膚腺 (JP Patent Analysis Report)
The Technical Field "皮膚腺" had 1,399 patent application filings in the most recent period (2022-01-01 to 2022-07-31). This is a significantly decreased of -838 filings (-37.5%) over 2,237 they had in the same period of the previous year (2021-01-01 to 2021-07-31). This report also includes technical terms related to " 皮せん ", " 皮腺 ", " 皮膚せん " in the search set.
The highest number of filings in 2016 with 4,681 cases, and their lowest number in 2022 with 1,672 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 18,678 cases in total) is 3,113, and the median is 3,864. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 3,113 patents |
| Std Dev | 1,648 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 1,672 cases | -56.2 % |
| 2021 year | 3,813 cases | -2.58 % |
| 2020 year | 3,914 cases | -12.52 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 皮膚腺 for the period of the last 10 years (2014-01-01 to 2024-03-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 皮膚腺, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
皮膚腺, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 皮膚腺 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 36,475 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
皮膚腺
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 皮膚腺 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Comparing the number of applications of each company, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 62 cases, followed by 株式会社資生堂 with 23 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 62 cases |
| 株式会社資生堂 | 23 cases |
| ロレアル | 19 cases |
| ポーラ化成工業株式会社 | 14 cases |
| 株式会社コーセー | 12 cases |
| ライオン株式会社 | 9 cases |
| ザプロクターアンドギャンブルカンパニー | 7 cases |
| コーニンクレッカフィリップスエヌヴェ | 7 cases |
| 株式会社ノエビア | 4 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Comparing the number of applications of each company, 花王株式会社 has the highest number of joint applications in the last for the target period (2014 to 2024) with 669 cases, followed by ロレアル with 594 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 669 cases |
| ロレアル | 594 cases |
| コーニンクレッカフィリップスエヌヴェ | 429 cases |
| ザプロクターアンドギャンブルカンパニー | 248 cases |
| ポーラ化成工業株式会社 | 232 cases |
| 株式会社資生堂 | 221 cases |
| 株式会社コーセー | 157 cases |
| ライオン株式会社 | 87 cases |
| 株式会社ノエビア | 81 cases |
| ユニリーバー・ナームローゼ・ベンノートシヤープ | 57 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 皮膚腺 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Among the top coapplicants, 花王株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 62 cases, followed by 株式会社資生堂 with 23 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 62 cases |
| 株式会社資生堂 | 23 cases |
| ロレアル | 19 cases |
| ポーラ化成工業株式会社 | 14 cases |
| ライオン株式会社 | 9 cases |
| ザプロクターアンドギャンブルカンパニー | 7 cases |
| コーニンクレッカフィリップスエヌヴェ | 7 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Among the top coapplicants, 花王株式会社 has the highest number of joint applications in the last for the target period (2014 to 2024) with 669 cases, followed by ロレアル with 594 cases.
| Name | Cases |
|---|---|
| 花王株式会社 | 669 cases |
| ロレアル | 594 cases |
| コーニンクレッカフィリップスエヌヴェ | 429 cases |
| ザプロクターアンドギャンブルカンパニー | 248 cases |
| ポーラ化成工業株式会社 | 232 cases |
| 株式会社資生堂 | 221 cases |
| ライオン株式会社 | 87 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 皮膚腺’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 皮膚腺’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with ロレアル
皮膚腺 filed 594 joint applications with ロレアル for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 262 cases in total) is 43.7, and the median is 55.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 111 cases, and their lowest number in 2022 with 19 cases.
| Index | Value |
|---|---|
| Average | 43.7 patents |
| Std Dev | 25.3 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 19 cases | -66.7 % |
| 2021 year | 57 cases | +7.55 % |
| 2020 year | 53 cases | -17.19 % |
Trends in filing of joint patent applications with 花王株式会社
皮膚腺 filed 669 joint applications with 花王株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 376 cases in total) is 62.7, and the median is 74.0. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2021 with 90 cases, and their lowest number in 2022 with 55 cases.
| Index | Value |
|---|---|
| Average | 62.7 patents |
| Std Dev | 26.9 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 55 cases | -38.9 % |
| 2021 year | 90 cases | +18.42 % |
| 2020 year | 76 cases | +5.56 % |
Trends in filing of joint patent applications with 株式会社資生堂
皮膚腺 filed 221 joint applications with 株式会社資生堂 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 140 cases in total) is 23.3, and the median is 21.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2019 with 49 cases, and their lowest number in 2015 with 15 cases.
| Index | Value |
|---|---|
| Average | 23.3 patents |
| Std Dev | 13.6 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 20 cases | +5.26 % |
| 2021 year | 19 cases | -13.64 % |
| 2020 year | 22 cases | -55.1 % |
Trends in filing of joint patent applications with ポーラ化成工業株式会社
皮膚腺 filed 232 joint applications with ポーラ化成工業株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 125 cases in total) is 20.8, and the median is 24.0. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The highest number of filings in 2014 with 34 cases, and their lowest number in 2022 with 14 cases.
| Index | Value |
|---|---|
| Average | 20.8 patents |
| Std Dev | 11.2 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 14 cases | -46.2 % |
| 2021 year | 26 cases | -23.53 % |
| 2020 year | 34 cases | +54.5 % |
Trends in filing of joint patent applications with ザプロクターアンドギャンブルカンパニー
皮膚腺 filed 248 joint applications with ザプロクターアンドギャンブルカンパニー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 89 cases in total) is 14.8, and the median is 14.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2014 with 53 cases, and their lowest number in 2022 with 6 cases.
| Index | Value |
|---|---|
| Average | 14.8 patents |
| Std Dev | 10.5 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 6 cases | -50.0 % |
| 2021 year | 12 cases | -36.8 % |
| 2020 year | 19 cases | +11.76 % |
Information on important patents (JP)
The following shows JP patents held by 皮膚腺 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 皮膚腺’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 皮膚腺 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 8 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許6189374 "糖尿病療法" (Invalidation Trial day 2024-01-31) , next is 特許7185426 "Ｓ１Ｐ受容体モジュレーターの投与計画" (Invalidation Trial day 2023-07-10) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許6189374 | 糖尿病療法 | 2024-01-31 |
| 2 | 特許7185426 | Ｓ１Ｐ受容体モジュレーターの投与計画 | 2023-07-10 |
| 3 | 特許5474043 | （＋）−２−［１−（３−エトキシ−４−メトキシフェニル）−２−メチルスルホニルエチル］−４−アセチルアミノイソインドリン−１，３−ジオンを含む固形物形態、その組成物およびその使用 | 2023-05-31 |
| 4 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 2023-03-27 |
| 5 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
| 6 | 特許4414623 | 病原微生物および抗微生物剤の検出法、抗微生物剤の薬効評価法ならびに抗微生物剤 | 2023-01-11 |
| 7 | 特許6914336 | 進行したＨＥＲ２発現がんの治療 | 2022-11-15 |
| 8 | 特許6966812 | 皮膚刺激ブラシ | 2022-05-02 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 6 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許7016341 "ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法" (1 times) , and the next most invalidation trial patent is 特許6966812 "皮膚刺激ブラシ" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 1 times |
| 2 | 特許6966812 | 皮膚刺激ブラシ | 1 times |
| 3 | 特許6896700 | ワクチン組成物 | 1 times |
| 4 | 特許6189374 | 糖尿病療法 | 1 times |
| 5 | 特許6258428 | 肺癌治療剤 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 65 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7298844 "細胞培養物の製造方法" (Opposition day 2023-12-26) , next is 特許7290765 "油中水型乳化組成物" (Opposition day 2023-12-08) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7298844 | 細胞培養物の製造方法 | 2023-12-26 |
| 2 | 特許7290765 | 油中水型乳化組成物 | 2023-12-08 |
| 3 | 特許7282155 | 頭皮用外用組成物 | 2023-11-24 |
| 4 | 特許7275336 | アルミニウム合金材の製造方法及びアルミニウム合金材 | 2023-11-17 |
| 5 | 特許7270996 | 美容組成物 | 2023-11-10 |
| 6 | 特許7272806 | 皮膚化粧料 | 2023-10-31 |
| 7 | 特許7266389 | 揚げ物改良用組成物およびこれを用いる揚げ物の製造方法 | 2023-10-27 |
| 8 | 特許7266260 | 調味オイル及びその製造方法、液体調味料、食品及びその製造方法 | 2023-10-27 |
| 9 | 特許7246987 | Ｏ／Ｗ型乳化組成物 | 2023-09-28 |
| 10 | 特許7244922 | 化学修飾された一本鎖ＲＮＡ編集オリゴヌクレオチド | 2023-09-20 |
Protested cases
List of latest Protested patents
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 325 patents Protest from third parties. The average number of Protest is 1.4 times. The most recently Protest patent is 特開2021-104933 "粉末化粧用組成物" (Protest day 2024-03-11) , next is 特開2020-022742 "肌状態の改善方法" (Protest day 2024-03-11) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2021-104933 | 粉末化粧用組成物 | 2024-03-11 |
| 2 | 特開2020-022742 | 肌状態の改善方法 | 2024-03-11 |
| 3 | 特表2023-519172 | 胃腸微生物代謝経路及び代謝物を調節する方法 | 2024-03-08 |
| 4 | 特許7464243 | かゆみを伴う乾燥性皮膚の治療薬 | 2024-02-20 |
| 5 | 特開2022-044197 | 固形状皮膚洗浄用組成物 | 2024-02-17 |
| 6 | 特開2023-004147 | 皮膚洗浄剤組成物 | 2024-02-17 |
| 7 | 特開2023-175853 | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 | 2024-02-16 |
| 8 | 特開2022-025713 | 紫外線暴露により誘発される皮膚障害の軽減又は抑制用経口組成物 | 2024-02-14 |
| 9 | 特許7038388 | 医療システム及びそれを実行する方法 | 2024-02-14 |
| 10 | 特開2023-029502 | 血流改善剤 | 2024-02-13 |
| 11 | 特表2022-541411 | 組換えスパイダーシルク押出物製剤 | 2024-02-13 |
| 12 | 特開2022-068362 | 医療システム及びそれを実行する方法 | 2024-02-10 |
| 13 | 特開2021-116232 | 水中油型乳化組成物 | 2024-02-07 |
| 14 | 特開2021-066726 | 皮膚外用剤 | 2024-02-05 |
| 15 | 特開2021-143204 | 皮膚清拭用組成物 | 2024-01-30 |
| 16 | 特開2023-165949 | 皮膚外用剤 | 2024-01-30 |
| 17 | 特表2022-504702 | 緩衝塩及びアミノ酸を含有する粉末、そのような粉末の栄養製品への再構成、並びにそのような栄養製品を使用する方法 | 2024-01-30 |
| 18 | 特許7416107 | ＲＨ真空脱ガス槽の下部槽構造及びＲＨ真空脱ガス設備 | 2024-01-24 |
| 19 | 特開2021-075498 | 非水系組成物および毛髪処理方法 | 2024-01-24 |
| 20 | 特開2021-075499 | 非水系組成物および毛髪処理方法 | 2024-01-24 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 580 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.4. The most protest patent is 特許7150411 "水中油型乳化化粧料" (7 times) , and the next most protest patent is 特開2020-193227 "外用組成物" (7 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7150411 | 水中油型乳化化粧料 | 7 times |
| 2 | 特開2020-193227 | 外用組成物 | 7 times |
| 3 | 特許6764792 | ケラチン処理調合物及び方法 | 6 times |
| 4 | 特開2023-029502 | 血流改善剤 | 6 times |
| 5 | 特許7058943 | 水中油型乳化組成物 | 6 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2021-04-01 ~ 2024-03-31), there were 666 patents Inspection from third parties. The average number of Inspection is 1.6 times. The most recently Inspection patent is 特表2024-502934 "人工心臓弁装置、システム及び方法" (Inspection day 2024-03-25) , next is 特表2022-508807 "腫瘍内注射製剤" (Inspection day 2024-03-19) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2024-502934 | 人工心臓弁装置、システム及び方法 | 2024-03-25 |
| 2 | 特表2022-508807 | 腫瘍内注射製剤 | 2024-03-19 |
| 3 | 特表2021-516049 | 組換えＴ細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 | 2024-03-19 |
| 4 | 特開2023-004147 | 皮膚洗浄剤組成物 | 2024-03-19 |
| 5 | 特表2023-525436 | ビグアニド系化合物、及びフラボン、ヒドロキシフラボン、フラバノン、フラボン誘導体、ヒドロキシフラボン誘導体、フラバノン誘導体の複合剤を有効成分として含有する癌の予防または治療用薬学的組成物 | 2024-03-18 |
| 6 | 特表2023-528059 | 抗ウイルス剤及び抗うつ剤を有効成分として含有する癌の予防または治療用薬学的組成物 | 2024-03-18 |
| 7 | 特開2022-107365 | 皮膚外用組成物 | 2024-03-18 |
| 8 | 特開2022-044197 | 固形状皮膚洗浄用組成物 | 2024-03-14 |
| 9 | 特開2018-005928 | 最適化された栄養処方物、それらから目的に合わせた食事を選択するための方法、およびその使用法 | 2024-03-13 |
| 10 | 特表2021-534146 | アセチル−ＣＯＡカルボキシラーゼ２アンチセンスオリゴヌクレオチド | 2024-03-12 |
| 11 | 特開2022-025713 | 紫外線暴露により誘発される皮膚障害の軽減又は抑制用経口組成物 | 2024-03-11 |
| 12 | 特開2023-175853 | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 | 2024-03-11 |
| 13 | 特開2021-066726 | 皮膚外用剤 | 2024-03-07 |
| 14 | 特開2021-051749 | 最適化された栄養処方物、それらから目的に合わせた食事を選択するための方法、およびその使用法 | 2024-03-07 |
| 15 | 特許7038388 | 医療システム及びそれを実行する方法 | 2024-03-07 |
| 16 | 特許7459360 | 水中油型乳化組成物 | 2024-03-06 |
| 17 | 特許6321773 | ハウジング内の物体、及びハウジングを開放するための機構を有する組立体 | 2024-03-06 |
| 18 | 特開2022-068362 | 医療システム及びそれを実行する方法 | 2024-03-04 |
| 19 | 特開2021-123532 | 皮膚外用組成物 | 2024-02-29 |
| 20 | 特開2023-165949 | 皮膚外用剤 | 2024-02-27 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 1,236 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.5. The most inspection patent is 特開2017-149726 "Ｂ細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療" (46 times) , and the next most inspection patent is 特許7376250 "皮膚外用組成物" (30 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2017-149726 | Ｂ細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療 | 46 times |
| 2 | 特許7376250 | 皮膚外用組成物 | 30 times |
| 3 | 特許6407064 | 両親媒性ポリマーを含む水中油型エマルジョン | 25 times |
| 4 | 特許7058943 | 水中油型乳化組成物 | 19 times |
| 5 | 特開2020-117500 | 皮膚外用組成物 | 17 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2014-04-01 to 2024-03-31), 6,397 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.4. The most cited patent is 特許6594413 "携帯デバイスを介する非侵襲的神経刺激" (57 times) , and the next most cited patent is 特開2016-035646 "触覚装置、および、それを有する触覚ディスプレイ" (47 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6594413 | 携帯デバイスを介する非侵襲的神経刺激 | 57 times |
| 2 | 特開2016-035646 | 触覚装置、および、それを有する触覚ディスプレイ | 47 times |
| 3 | 特開2015-027309 | ビール風味付与剤およびビール風味飲料 | 46 times |
| 4 | 特許6280287 | タバコ植物または非タバコ植物を用いた電子タバコカートリッジおよびその支持部材 | 46 times |
| 5 | 特開2019-019077 | 皮膚外用組成物 | 43 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.